Company Overview
IRONWOOD PHARMACEUTICALS INC
IRWDRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
296M
2025 FY
Net Income
24M
2025 FY
Shares Outstanding
162M
2025 FY
EPS
0.15USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1446847
Exchange
Nasdaq
Location
US